Webinar: Weekly Triggers Fuel Omni Channel Marketing Impact in Healthcare
Reports have shown that up to 69% of physicians want digital patient education and are up to 5X more responsive to messaging if personalized. The future of pharma is personalized omni-channel engagement, and that future is now.
TI Health’s predictive analytics Affiniti™ platform can engage providers and patients using the right message, the right channel, with the right approach. In partnership with Symphony Health™ we’re incorporating weekly trigger data to power real-time programs.
Join us to learn more about how we’re combining personalization with non-personal promotion to deliver 160:1 ROI for leading pharmaceutical brands.
Co-President and Chief Commercial Officer
Erin DeRuggiero is a fast-rising healthcare entrepreneur and executive, leading change in healthcare innovation, predictive analytics and machine learning, female-led startups and gender equity.
As CEO of TI Health, Erin has more than 20 years of digital advertising, data and healthcare marketing experience. She works with pharmaceutical manufacturers, medical devices and their respective advertising agencies to creating palpable, positive outcomes for hundreds of therapeutics, devices and brands.
Prior to TI Health, Erin co-founded SRAX, an ad tech startup with a business unit devoted to healthcare, successfully up-listing to NASDAQ two years post launch, a milestone for a female-led startup taking a company public.
Erin served as SRAX’s Chief Innovations Officer until the acquisition and carve out of the healthcare business she pioneered in August 2018.
Prior to launching SRAX, Erin served as Vice President of Innovation & Digital Strategy for the Lime Ad Network, a subsidiary of Gaiam, Inc, where she oversaw strategic digital partnerships and acquisitions. She also served as the Chief Revenue Officer for JGG Consulting, a successful brand strategy consultancy she founded, servicing consumer packaged goods and retail brand marketers.
Erin graduated from Macalester College in St Paul, MN and splits her time between New York and Maine.
Senior Product Director, Promotional Effectiveness
Ms. Hayes leads the design and development of innovative analytics and tools which enhance marketing and sales effectiveness using healthcare encounter insights, promotional data, and other client data. She has designed machine learning and decision guidance approaches to better predict diagnoses, disease progression, and predict the most effective tactics to best engage a customer in real time.
In her prior role, Ms. Hayes worked with some of the industry’s largest clients to support them in understanding unmet medical needs and commercial opportunities, developing award winning sales and marketing software, and facilitating better diagnosis, earlier treatment and outcomes using machine learning algorithms and advanced modeling techniques.
Previously, Ms. Hayes served as Vice President, Marketing of ArcLight reporting to the CEO. In this role she was responsible for planning and directing marketing of products and services including portfolio strategy, product definition, product marketing and communications strategy. Ms. Hayes joined Arclight from Oncology Therapeutics Network (OTN) where she was Director of Information Services and E-Commerce. She was instrumental in developing and marketing oncology treatment information products, tools and services to the pharmaceutical industry. She also developed customer facing web services for OTN’s award winning website.
In addition, Ms. Hayes has over 15 years of pharmaceutical industry experience. After progressing through a number of sales and sales management roles, her last role at Bristol Myers was leading a multi-departmental team to develop models and processes to enhance customer segmentation, sales forecasting and the measurement marketing effectiveness. Ms. Hayes holds a BS degree in biology/psychobiology from the University of California, Irvine.
Date: Tuesday, November 16, 2021
Time: 11am ET/8am PT
Duration: 1 Hour
Register now for this webinar